DOCETAXEL INDUCED PNEUMONITIS IN PATIENTS WITH METASTATIC PROSTATE CANCER

被引：0
|
作者：
Arasaratnam, Malmaruha [1 ]
Crumbaker, Megan [2 ]
Boys, Emma L. [1 ]
Gao, Bo [1 ]
Gurney, Howard [1 ,3 ]
机构：
[1] Westmead Hosp, Crown Princess Mary Canc Ctr, Med Oncol, Sydney, NSW, Australia
[2] Kinghord Canc Ctr, Med Oncol, Sydney, NSW, Australia
[3] Macquarie Univ, Med Oncol, Sydney, NSW, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
100
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [31] Clinicopathological predictors of favourable response to docetaxel in patients with metastatic castration-resistant prostate cancer
    Bentick, G.
    Balasubramanian, A.
    Anton, A.
    Azad, A.
    Brown, S.
    Goh, J. C. H.
    Wong, S. S. L.
    Parente, P.
    Shapiro, J.
    Liow, E. C. H.
    Torres, J.
    Smith, A.
    Steer, C.
    Warren, M.
    Gibbs, P.
    Tran, B.
    Weickhardt, A. J.
    ANNALS OF ONCOLOGY, 2024, 35
  • [32] Sequencing new agents after docetaxel in patients with metastatic castration-resistant prostate cancer
    Maines, Francesca
    Caffo, Orazio
    Veccia, Antonello
    Trentin, Chiara
    Tortora, Giampaolo
    Galligioni, Enzo
    Bria, Emilio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 96 (03) : 498 - 506
  • [33] SEQUENCING NEW AGENTS AFTER DOCETAXEL IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Maines, Francesca
    Caffo, Orazio
    Veccia, Antonello
    Tortora, Giampaolo
    Galligioni, Enzo
    Bria, Emilio
    ANTICANCER RESEARCH, 2015, 35 (06) : 3716 - 3716
  • [34] SUNITINIB IN COMBINATION WITH DOCETAXEL AND PREDNISONE IN PATIENTS WITH METASTATIC HORMONE-REFRACTORY PROSTATE CANCER (MHRPC)
    Zurita, A. J.
    Logothetis, C. J.
    Liu, G.
    Wilding, G.
    Hutson, T. E.
    Chen, I.
    Chow-Maneval, E.
    George, D. J.
    ANNALS OF ONCOLOGY, 2008, 19 : 198 - 198
  • [35] Docetaxel Chemotherapy Retreatment in Patients with Metastatic Hormone Refractory Prostate Cancer: Efficacy and Toxicity Analysis
    Ansari, J.
    Zarkar, A.
    Hussain, S. A.
    Tanguay, J.
    Bliss, J.
    Glaholm, J.
    CLINICAL ONCOLOGY, 2009, 21 (01) : 67 - 67
  • [36] Docetaxel and cisplatin in patients with metastatic androgen independent prostate cancer and circulating neuroendocrine markers - Comment
    Laber, Damian A.
    JOURNAL OF UROLOGY, 2007, 178 (03): : 848 - 848
  • [37] TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS PREVIOUSLY TREATED WITH DOCETAXEL IN PORTUGAL
    Silva Miguel, L.
    Paquete, A. T.
    Guerreiro, R.
    Fiorentino, F.
    Costa, J.
    Borges, M.
    VALUE IN HEALTH, 2018, 21 : S71 - S71
  • [38] Diethylstilbestrol and docetaxel: A phase II study in patients with metastatic, androgen independent prostate cancer.
    Montgomery, B
    Lin, D
    Ryan, C
    Garzotto, M
    Beer, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 437S - 437S
  • [39] Interstitial pneumonitis induced by bicalutamide given for prostate cancer
    Masago, Toshihiko
    Watanabe, Takeshi
    Nemoto, Ryosuke
    Motoda, Kinya
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (06) : 763 - 765
  • [40] Interstitial pneumonitis induced by bicalutamide given for prostate cancer
    Toshihiko Masago
    Takeshi Watanabe
    Ryosuke Nemoto
    Kinya Motoda
    International Journal of Clinical Oncology, 2011, 16 : 763 - 765
12345